Prolonged use of Plk1 inhibitors, which are currently in clinical trials with patients, can not only lead to hypertension issues but also to the rupturing of blood vessels and severe cardiovascular problems, new research concludes.
Prolonged use of Plk1 inhibitors, which are currently in clinical trials with patients, can not only lead to hypertension issues but also to the rupturing of blood vessels and severe cardiovascular problems, new research concludes.